You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GRCE Buy Disclosure
Opaleye Management Inc. · SEC Form 4 · Filed Oct 5, 2026
Buy
Calculated transaction value
$41.37K
Opaleye Management Inc. 10% owner
GRCE
Grace Therapeutics
GRCE
Transaction date
Oct 2, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed 3 days later
GRCE daily price context
Close on/before transaction
$2.07
Oct 2, 2026
First close after public filing
$2.06
Oct 6, 2026
30-day return after filing
-12.35%
Through Nov 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.0001 per share
- Quantity / price
- 20,000 shares @ $2.07
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-045809
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$123.82K
Buys / sales
3 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Grace Therapeutics, Inc. GRCE | Buy | Oct 5, 2026 | $3.49K |
| Grace Therapeutics, Inc. GRCE Current | Buy | Oct 2, 2026 | $41.37K |
| Grace Therapeutics, Inc. GRCE | Buy | Oct 1, 2026 | $78.96K |